↓ Skip to main content

Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
Published in
Orphanet Journal of Rare Diseases, February 2022
DOI 10.1186/s13023-022-02241-9
Pubmed ID
Authors

Sarah J. Howe, David Lapidus, Michael Hull, Jason Yeaw, Tanya Stevenson, Jacinda B. Sampson

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 10%
Student > Ph. D. Student 1 5%
Student > Doctoral Student 1 5%
Researcher 1 5%
Professor > Associate Professor 1 5%
Other 0 0%
Unknown 14 70%
Readers by discipline Count As %
Medicine and Dentistry 2 10%
Nursing and Health Professions 1 5%
Chemistry 1 5%
Economics, Econometrics and Finance 1 5%
Unknown 15 75%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2022.
All research outputs
#14,555,398
of 23,310,485 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,602
of 2,673 outputs
Outputs of similar age
#218,091
of 441,978 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#63
of 140 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,673 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,978 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.